KFF has conducted this annual survey since 1999.
Category: Kaiser Family Foundation
Benchmark Survey: Annual Family Premiums for Employer Coverage Rise 7% to Nearly $24,000 in 2023; Workers Contribute $6,575 on Average Now, But Potentially More Soon
Amid rising inflation, annual family premiums for employer-sponsored health insurance climbed 7% on average this year to reach $23,968, a sharp departure from virtually no growth in premiums last year, the 2023 benchmark KFF Employer Health Benefits Su…
How Does U.S. Life Expectancy Compare to Other Countries?
The analysis finds that life expectancy in the U.S. fell by 2.7 years from 2019 to 2021, whereas in peer countries’ life expectancies fell by an average of just 0.2 years in this period. COVID-19 has erased two decades of life expectancy growth in the …
How Much is Health Spending Expected to Grow?
This chart collection explores how health spending is expected to grow in coming years, based on National Health Expenditure projections from federal actuaries.
KFF Health News, NPR, and CBS News Win Loeb Award for Series on Medical Debt in America
KFF Health News won the 2023 Loeb Award in the personal finance and consumer reporting category for its in-depth coverage of consumer medical debt in its “Diagnosis: Debt” series. In partnership with NPR and CBS News, KFF Health News examined the stori…
Consumer Survey Highlights Problems with Denied Health Insurance Claims
This Data Note includes major findings from the KFF Consumer Survey on consumer experiences with claim denials. Among those who used the most health care over the past year, 27% experienced a denied claim. More consumers with private insurance experie…
Private Insurer Payments for Telehealth and In-Person Claims During the Pandemic
This analysis of 2021 claims data finds that while telehealth use remained high in the second year of the COVID-19 pandemic, the shift toward virtual physician and mental health care did not materially affect how much insurers paid for each patient enc…
How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs
This brief examines how Part D enrollees’ access to and utilization of the first set of 10 selected drugs could be affected by the new Part D coverage and formulary requirements for selected drugs established by the Inflation Reduction Act and in CMS g…
What are the recent and forecasted trends in prescription drug spending?
This slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
The 4 Arguments You Will Hear Against Drug Price Negotiation
As the Biden administration begins the process of negotiation drug prices for Medicare as authorized in the Inflation Reduction Act, KFF’s Larry Levitt probes some of the arguments against it and the policy and political implications of the debate in t…
